GO
Loading...

Pharma's Rare Disease Strategy

Wednesday, 23 May 2012 | 1:23 PM ET

Investors have made big bets on drugs like Pfizer's Lipitor for cholesterol, Glaxo's Advair for Asthma, and many more. CNBC's Seema Mody reports rare diseases might be the next hot investment.